Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity

Obsessive-compulsive disorder (OCD) has been recently drawn apart from anxiety disorder by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) and clustered together with related disorders (eg, hoarding, hair pulling disorder, skin picking), which with it seems to share clinical and neurophysiological similarities. Recent literature has mainly explored brain circuitries (eg, orbitofrontal cortex, striatum), molecular pathways, and genes (eg, Hoxb8, Slitrk5, Sapap3) that represent the new target of the treatments; they also lead the development of new probes and compounds. In the therapeutic field, monotherapy with cognitive behavioral therapy (CBT) or selective serotonin reuptake inhibitors (SSRIs) is recommendable, but combination or augmentation with a dopaminergic or glutamatergic agent is often adopted. A promising therapy for OCD is represented by repetitive transcranial magnetic stimulation (rTMS), which is suitable to treat compulsivity and impulsivity depending on the protocol of stimulation and the brain circuitries targeted.

[1]  A. Gershon,et al.  Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study , 2008, European Neuropsychopharmacology.

[2]  J. Warren.  Synaptic Self: How our Brains Become who we Are , 2002 .

[3]  S. Rossi,et al.  Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. , 2010, The international journal of neuropsychopharmacology.

[4]  Michael Davis,et al.  The role of the amygdala in fear and anxiety. , 1992, Annual review of neuroscience.

[5]  E. Hollander,et al.  Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. , 2011, The Journal of clinical psychiatry.

[6]  L. Koran,et al.  Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial. , 2002, The Journal of clinical psychiatry.

[7]  L. Koran,et al.  Pulse-Loaded Intravenous Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder , 2006, Journal of clinical psychopharmacology.

[8]  Sarah H Lisanby,et al.  Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). , 2005, The international journal of neuropsychopharmacology.

[9]  E. Hollander,et al.  Treatment non-response in OCD: methodological issues and operational definitions. , 2002, The international journal of neuropsychopharmacology.

[10]  T. Endrass,et al.  Approach and avoidance learning in obsessive–compulsive disorder , 2011, Depression and anxiety.

[11]  E. Hollander,et al.  A review of pharmacologic treatments for obsessive-compulsive disorder. , 2003, Psychiatric services.

[12]  S. Praharaj,et al.  Adjunctive high-frequency right prefrontal repetitive transcranial magnetic stimulation (rTMS) was not effective in obsessive-compulsive disorder but improved secondary depression. , 2010, Journal of anxiety disorders.

[13]  P. Mitchell,et al.  Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. , 2001, The Journal of clinical psychiatry.

[14]  R. Frost,et al.  Cognitive approaches to obsessions and compulsions : theory, assessment, and treatment , 2002 .

[15]  P. Lichtenstein,et al.  Population-based, multigenerational family clustering study of obsessive-compulsive disorder. , 2013, JAMA psychiatry.

[16]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[17]  M. Capecchi.  Hox genes and mammalian development. , 1997, Cold Spring Harbor symposia on quantitative biology.

[18]  D. Woods,et al.  How related are hair pulling disorder (trichotillomania) and skin picking disorder? A review of evidence for comorbidity, similarities and shared etiology. , 2012, Clinical psychology review.

[19]  H. Westenberg,et al.  Dysfunctional Reward Circuitry in Obsessive-Compulsive Disorder , 2011, Biological Psychiatry.

[20]  S. Haber,et al.  The Reward Circuit: Linking Primate Anatomy and Human Imaging , 2010, Neuropsychopharmacology.

[21]  E. Bullmore,et al.  Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited , 2008, Neuroscience & Biobehavioral Reviews.

[22]  Z. Demetrovics,et al.  Association between Novelty Seeking of opiate-dependent patients and the catechol-O-methyltransferase Val(158)Met polymorphism. , 2010, Comprehensive psychiatry.

[23]  S. Starkstein,et al.  A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[24]  Christian Kaufmann,et al.  Fronto-striato-limbic hyperactivation in obsessive-compulsive disorder during individually tailored symptom provocation. , 2010, Psychophysiology.

[25]  J. Mazziotta,et al.  Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. , 1988, The American journal of psychiatry.

[26]  K. Namkoong,et al.  A randomized controlled study of sequentially applied repetitive transcranial magnetic stimulation in obsessive-compulsive disorder. , 2009, The Journal of clinical psychiatry.

[27]  Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial. , 2009, Psychopharmacology bulletin.

[28]  Dick J. Veltman,et al.  Amygdala activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography , 2004, Psychiatry Research: Neuroimaging.

[29]  J. Zohar,et al.  Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder , 2011, CNS drugs.

[30]  Frank H. Burton,et al.  Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette’s syndrome and obsessive–compulsive disorder , 2000, Brain Research.

[31]  Frank H. Burton,et al.  A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry , 2002, Molecular Psychiatry.

[32]  C. Beaulieu,et al.  The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.

[33]  E. Hollander,et al.  FDG-PET Study in Pathological Gamblers , 2008, Neuropsychobiology.

[34]  G. Grassi,et al.  Obsessive–Compulsive Disorder Comorbidity: Clinical Assessment and Therapeutic Implications , 2011, Front. Psychiatry.

[35]  B. Harrison,et al.  Altered Cortico-Striatal Functional Connectivity in Obsessive-Compulsive Disorder , 2009, NeuroImage.

[36]  J. Rapoport,et al.  Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. , 1989, Archives of general psychiatry.

[37]  K. Phillips,et al.  Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine. , 1999, Psychosomatics.

[38]  D. Sookman,et al.  Overestimation of Threat and Intolerance of Uncertainty in Obsessive Compulsive Disorder , 2002 .

[39]  L. Lange,et al.  Sweet liking and high novelty seeking: independent phenotypes associated with alcohol-related problems. , 2010, Alcohol and alcoholism.

[40]  G. Willemsen,et al.  Marital resemblance for obsessive–compulsive, anxious and depressive symptoms in a population-based sample , 2008, Psychological Medicine.

[41]  L. Koran,et al.  Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. , 2005, The Journal of clinical psychiatry.

[42]  Michael E Phelps,et al.  FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder , 1998, Psychiatry Research: Neuroimaging.

[43]  E. Storch,et al.  DIFFICULT‐TO‐TREAT PEDIATRIC OBSESSIVE‐COMPULSIVE DISORDER: FEASIBILITY AND PRELIMINARY RESULTS OF A RANDOMIZED PILOT TRIAL OF d‐CYCLOSERINE‐AUGMENTED BEHAVIOR THERAPY , 2013, Depression and anxiety.

[44]  Kamryn T. Eddy,et al.  Amygdala-frontal connectivity during emotion regulation. , 2007, Social cognitive and affective neuroscience.

[45]  Long-Term Follow-Up Study of Patients With Refractory Obsessive-Compulsive Disorder , 2008 .

[46]  S. Akhondzadeh,et al.  Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder , 2012, CNS Drugs.

[47]  E. Smeraldi,et al.  Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation. , 2009, Primary care companion to the Journal of clinical psychiatry.

[48]  A Ahonen,et al.  Dopamine Transporter Density and Novelty Seeking Among Alcoholics , 2001, Journal of addictive diseases.

[49]  R. Goldstein,et al.  The demography, phenomenology, and family history of 22 persons with compulsive hair pulling. , 1994, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[50]  P. Whalen,et al.  The Structural Integrity of an Amygdala–Prefrontal Pathway Predicts Trait Anxiety , 2009, The Journal of Neuroscience.

[51]  T. Insel,et al.  Toward a neuroanatomy of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[52]  M. Pompili,et al.  Functional Neuroimaging in Obsessive-Compulsive Disorder , 2011, Neuropsychobiology.

[53]  J. Thome,et al.  Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology , 2003, Journal of Neural Transmission.

[54]  E. Aboujaoude,et al.  Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: An Open-Label Trial , 2009, Journal of clinical psychopharmacology.

[55]  D. Belin,et al.  Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: A review , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[56]  E. Hollander,et al.  Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder , 2009, CNS drugs.

[57]  R. Baldessarini,et al.  Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both , 2006, Human psychopharmacology.

[58]  J. McGeary,et al.  GENETIC STUDY: The dopamine D4 Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects , 2009 .

[59]  Kent A. Kiehl,et al.  Dysfunctional Action Monitoring Hyperactivates Frontal–striatal Circuits in Obsessive–compulsive Disorder: an Event-related Fmri Study , 2004 .

[60]  Michael B. First,et al.  A Research Agenda for DSM-V , 2002 .

[61]  Thomas J. H. Chen,et al.  The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors , 2000, Journal of psychoactive drugs.

[62]  D. Murphy,et al.  Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. , 1997, The American journal of psychiatry.

[63]  Darin D Dougherty,et al.  Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder , 2001, Biological Psychiatry.

[64]  A Ahonen,et al.  The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics. , 2001, Alcohol and alcoholism.

[65]  J. Pujol,et al.  Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study. , 2001, The American journal of psychiatry.

[66]  Tommy Pattij,et al.  Dopamine receptor D1/D5 gene expression in the medial prefrontal cortex predicts impulsive choice in rats. , 2010, Cerebral cortex.

[67]  W. Gehring,et al.  Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder , 2005, Biological Psychiatry.

[68]  C. Pittenger,et al.  Systematic Review: Pharmacological and Behavioral Treatment for Trichotillomania , 2007, Biological Psychiatry.

[69]  S. Dulawa,et al.  Essential Role for Orbitofrontal Serotonin 1B Receptors in Obsessive-Compulsive Disorder-Like Behavior and Serotonin Reuptake Inhibitor Response in Mice , 2011, Biological Psychiatry.

[70]  Steven C. R. Williams,et al.  Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers , 2003, Biological Psychiatry.

[71]  G. Feng,et al.  Sapap3 Deletion Causes mGluR5-Dependent Silencing of AMPAR Synapses , 2011, The Journal of Neuroscience.

[72]  H. Uylings,et al.  Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. , 2006, Archives of general psychiatry.

[73]  Y. Janardhan Reddy,et al.  DRD4 gene and obsessive compulsive disorder: Do symptom dimensions have specific genetic correlates? , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[74]  Kristen K. Ade,et al.  Circuit-Selective Striatal Synaptic Dysfunction in the Sapap3 Knockout Mouse Model of Obsessive-Compulsive Disorder , 2013, Biological Psychiatry.

[75]  Shahin Rafii,et al.  Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice , 2010, Nature Medicine.

[76]  Petr Tvrdik,et al.  Hematopoietic Origin of Pathological Grooming in Hoxb8 Mutant Mice , 2010, Cell.

[77]  M. Kringelbach.  The human orbitofrontal cortex: linking reward to hedonic experience , 2005, Nature Reviews Neuroscience.

[78]  A. Ibáñez,et al.  The extended fronto-striatal model of obsessive compulsive disorder: convergence from event-related potentials, neuropsychology and neuroimaging , 2012, Front. Hum. Neurosci..

[79]  M. Caron,et al.  OCD-Like Behaviors Caused by a Neuropotentiating Transgene Targeted to Cortical and Limbic D1+ Neurons , 1999, The Journal of Neuroscience.

[80]  Sarah H. Lisanby,et al.  Functional Magnetic Resonance Imaging Guided Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder , 2010, Biological Psychiatry.

[81]  L. Kegeles,et al.  Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept , 2013, Neuropsychopharmacology.

[82]  Z. Tunca,et al.  Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression , 2001, Psychiatry Research: Neuroimaging.

[83]  A. Sahraian,et al.  Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial , 2010, CNS Spectrums.

[84]  D. Murphy,et al.  Phenomenological features and clinical impact of affective disorders in OCD: a focus on the bipolar disorder and ocd connection , 2012, Depression and anxiety.

[85]  R. Depue,et al.  Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion , 1999, Behavioral and Brain Sciences.

[86]  T. Robbins,et al.  Orbitofrontal Dysfunction in Patients with Obsessive-Compulsive Disorder and Their Unaffected Relatives , 2008, Science.

[87]  A L Brody,et al.  Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder , 1998, British Journal of Psychiatry.

[88]  T. Hendler,et al.  Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD , 2003, Psychiatry Research: Neuroimaging.

[89]  M. Potenza,et al.  Addicted to Hair Pulling? How an Alternate Model of Trichotillomania May Improve Treatment Outcome , 2007, Harvard review of psychiatry.

[90]  Robert T. Rubin,et al.  Psychopharmacology: The Fourth Generation of Progress: An Official Publication of the American College of Neuropsychopharmacology , 1996 .

[91]  E. Storch,et al.  Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale. , 2010, Psychological assessment.

[92]  Erik Woody,et al.  Obsessive-compulsive disorder as a disturbance of security motivation. , 2004, Psychological review.

[93]  S. E. Stewart,et al.  Meta‐analysis of association between obsessive‐compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1 , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[94]  B. Aouizerate,et al.  Pathophysiology of obsessive–compulsive disorder A necessary link between phenomenology, neuropsychology, imagery and physiology , 2004, Progress in Neurobiology.

[95]  Dan J Stein.  Advances in understanding the anxiety disorders: the cognitive-affective neuroscience of 'false alarms'. , 2006, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[96]  John Suckling,et al.  White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. , 2008, The American journal of psychiatry.

[97]  S. Rauch,et al.  Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. , 2003, Psychopharmacology bulletin.

[98]  D. Stein,et al.  Cluster analysis of obsessive-compulsive symptomatology: identifying obsessive-compulsive disorder subtypes. , 2008, The Israel journal of psychiatry and related sciences.

[99]  L. Koran,et al.  Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. , 2009, The Journal of clinical psychiatry.

[100]  S. Dudek,et al.  Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice , 2007, Nature.

[101]  Joseph M. Antony.  Grooming and Growing with Microglia , 2010, Science Signaling.

[102]  S. Rauch,et al.  Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways , 2012, Trends in Cognitive Sciences.

[103]  Y Wang,et al.  Genome-wide association study of obsessive-compulsive disorder , 2013, Molecular Psychiatry.

[104]  M. Bareš,et al.  The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. , 2006, Neuro endocrinology letters.

[105]  S. Rauch,et al.  Neurobiology of emotion perception II: implications for major psychiatric disorders , 2003, Biological Psychiatry.

[106]  S. Saxena.  Pharmacotherapy of compulsive hoarding. , 2011, Journal of clinical psychology.

[107]  E. Hollander,et al.  A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder. , 2004, The Journal of clinical psychiatry.

[108]  W. Ecker,et al.  Incompleteness as a link between obsessive-compulsive personality traits and specific symptom dimensions of obsessive-compulsive disorder. , 2014, Clinical psychology & psychotherapy.

[109]  N. Fineberg,et al.  Evidence-based treatment pathways for translational studies in obsessive-compulsive disorders. , 2013, Modern trends in pharmacopsychiatry.

[110]  S. Rauch,et al.  Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. , 2000, The Psychiatric clinics of North America.

[111]  P. Mitchell,et al.  Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation , 2007, Psychological Medicine.

[112]  M. Hirschtritt,et al.  An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. , 2007, Journal of child and adolescent psychopharmacology.

[113]  J. Greer,et al.  Hoxb8 Is Required for Normal Grooming Behavior in Mice , 2002, Neuron.

[114]  Citalopram Pulse-Loading for Severe Treatment-Resistant OCD: A Case Series of Acute Response, One Year Follow-Up and Tolerability , 2013 .